Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adrenergic Contribution to Glucose Counterregulation in Islet Transplantation
NCT03079921Phase 1Completed
- Sponsor
- University of Pennsylvania
- Start
- Jan 2017
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of phentolamine and propranolol in type 1 diabetes mellitus (T1D) and hypoglycemia (5 arms), sponsored by University of Pennsylvania. Primary endpoints: C-Peptide Suppression During Hyperinsulinemia Euglycemia and Glucagon Activation During Hyperinsulinemia Hypoglycemia. Started Jan 2017; status: completed.
02
Drugs
phentolaminepropranolol
03
Conditions
type 1 diabetes mellitus (T1D)hypoglycemia
Beyond the preview
Go deeper on NCT03079921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03079921.